Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints

Statistical Methods in Medical Research(2025)10.1177/09622802251343599Source: DataRank Database

Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints is a research paper published in Statistical Methods in Medical Research (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.29)OA: greenTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Han Yu ORCID,Alan D. Hutson ORCID

Live enrichment

PubMed:40551565 OpenAlex:https://openalex.org/W4411613726

National Institutes of Health

Grant: U10CA180822

National Institutes of Health

Grant: U24CA232979

National Institutes of Health

Grant: U24CA274159

FWCI

1.29

Citation Percentile

0.8%

Citation Trend

2025

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13403021/

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/09622802251343599

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/09622802251343599

journalhttps://doi.org/10.1177/09622802251343599

Fields of Study

Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesStatistical Methods and InferenceHumansRandomized Controlled Trials as TopicClinical Trials, Phase II as TopicLung NeoplasmsEndpoint DeterminationMedical OncologyModels, StatisticalSmall Cell Lung CarcinomaSample SizeData Interpretation, Statistical

MeSH Terms

Data Interpretation, StatisticalHumansLung NeoplasmsMedical OncologyModels, StatisticalRandomized Controlled Trials as TopicClinical Trials, Phase II as TopicSample SizeEndpoint DeterminationSmall Cell Lung Carcinoma

Keywords

Sample size determinationClinical trialMedicineRandomizationLog-rank testStatisticsMetric (unit)Statistical powerStatistical hypothesis testingEarly stoppingMedical physicsComputer scienceOncologySurvival analysisInternal medicineMathematicsMachine learningRandomization testPermutation TestMinimizationReal World Data

Sustainable Development Goals

SDG 0: Good health and well-being

Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints

FAIR Checklist

Authors (2)

Funding (3 grants)

Impact

Open Access

Topics